Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - LONG-TERM DEBT
Long-term Debt LRMR - Larimar Therapeutics, Inc.
4.71 M
LAST VALUE
-6.69%
2 YEAR CAGR
-20.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR